| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 10x Genomics, Inc. | Chief Financial Officer | Class A Common Stock | 297,385 | $5,649,809 | $19.00 | 24 Nov 2025 | Direct |
| SomaLogic, Inc. | Interim CEO | Common Stock | 0 | $2.43 | 05 Jan 2024 | Direct | |
| SomaLogic, Inc. | Interim CEO | Restricted Stock Unit | 0 | $2.43 | 05 Jan 2024 | Direct | |
| SomaLogic, Inc. | Interim CEO | Stock Option (Right to buy) | 0 | 05 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | 24 Nov 2025 | 1 | -$225,852 | 4 | Chief Financial Officer | 25 Nov 2025, 17:24 |
| TXG | 10x Genomics, Inc. | 22 Aug 2025 | 1 | -$307,657 | 4 | Chief Financial Officer | 26 Aug 2025, 16:14 |
| TXG | 10x Genomics, Inc. | 22 May 2025 | 1 | -$33,562 | 4 | Chief Financial Officer | 27 May 2025, 17:06 |
| TXG | 10x Genomics, Inc. | 23 Oct 2024 | 2 | $0 | 4 | Chief Financial Officer | 19 Mar 2025, 17:34 |
| TXG | 10x Genomics, Inc. | 12 Aug 2024 | 0 | $0 | 3 | Chief Financial Officer | 20 Aug 2024, 16:35 |
| SLGC | SomaLogic, Inc. | 05 Jan 2024 | 12 | $0 | 4 | Interim CEO | 09 Jan 2024, 21:54 |
| SLGC | SomaLogic, Inc. | 08 Jun 2023 | 2 | $0 | 4 | Interim CEO | 12 Jun 2023, 21:28 |
| SLGC | SomaLogic, Inc. | 28 Mar 2023 | 0 | $0 | 3 | Interim CEO | 07 Apr 2023, 19:08 |
| SLGC | SomaLogic, Inc. | 02 Mar 2023 | 2 | -$53,898 | 4 | Interim CEO | 02 Oct 2023, 18:39 |